The body of an individual suffering from type 1 diabetes does not produce insulin because of the immune system damaging cells that develop with insulin.
The results revealed that harmful T-cells have disappeared, and some have even started to produce insulin by themselves.
Dr. Denise Faustman, director of the Massachusetts General Immunobiology facility in Boston, is extremely excited about the results of the BCG vaccine has been revealing.
“In Phase I (preliminary) trial, we have demonstrated a statistically significant action for BCG, but our goal (this trial) is to develop a lasting restorative action.
There is a brand new trial to come. It will use the same format as the previous one on people at the age of 18 to 60. The subjects will be injected with the vaccine twice in a duration of 4 weeks. Then once a year for a period of 4 years.
The journal Diabetes Care has indeed published the results of a past study. She examined the impacts of Calmette-Guerin bacillus (BCG) on children with diabetes at the age between 5 and 18. The results revealed that the BCG vaccine does not keep the beta-function -cell. Or increase the rate of remission in children